← Back to Search

Amino Acid Supplement

Amino Acids for Aging

N/A
Waitlist Available
Led By Chad C Carroll, PhD
Research Sponsored by Purdue University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-6 hours post consumption
Awards & highlights

Study Summary

This trial will help determine if aging affects the delivery of amino acids to tendons after oral consumption, in order to optimize amino acid dosing for chronic interventional studies.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-6 hours post consumption
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-6 hours post consumption for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Achilles Peritendinous Amino Acid Levels in young and older adults

Side effects data

From 2020 Phase 2 trial • 39 Patients • NCT03273712
95%
Nausea
38%
Vomiting
38%
Fatigue
23%
Abdominal pain
21%
Headache
18%
Anemia
15%
Dizziness
13%
Fever
13%
Infusion site extravasation
13%
Lymphocyte count decreased
10%
Endocrine disorders - Other, specify
10%
White blood cell decreased
10%
Platelet count decreased
8%
Hypertension
8%
Diarrhea
8%
Chills
8%
Neutrophil count decreased
8%
Weight gain
8%
Arthralgia
5%
Pain in extremity
5%
Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify
5%
Constipation
5%
Infections and infestations - Other, specify
5%
Sepsis
5%
Eye disorders - Other, specify
5%
Small intestinal obstruction
5%
Pain
5%
Bronchial infection
5%
Back pain
5%
Dehydration
5%
Hyperkalemia
5%
Myalgia
5%
Anxiety
3%
Flu like symptoms
3%
General disorders and administration site conditions - Other, specify
3%
Musculoskeletal and connective tissue disorder - Other, specify
3%
Insomnia
3%
Flank pain
3%
Vascular disorders - Other, specify
3%
Renal and urinary disorders - Other, specify
3%
Syncope
3%
Gait disturbance
3%
Fall
3%
Alanine aminotransferase increased
3%
Abdominal distension
3%
Localized edema
3%
Urinary tract infection
3%
Lethargy
3%
Memory impairment
3%
Flushing
3%
Atrioventricular block complete
3%
Edema limbs
3%
Catheter related infection
3%
Aspartate aminotransferase increased
3%
Blood bilirubin increased
3%
Creatinine increased
3%
Hyperglycemia
3%
Hypokalemia
3%
Cardiac disorders - Other, specify
3%
Ear and labyrinth disorders - Other, specify
3%
Gastritis
3%
Gastrointestinal disorders - Other, specify
3%
Gastroparesis
3%
Hemorrhoidal hemorrhage
3%
Oral dysesthesia
3%
Upper gastrointestinal hemorrhage
3%
Edema face
3%
Injection site reaction
3%
Non-cardiac chest pain
3%
Hepatobiliary disorders - Other, specify
3%
Skin infection
3%
Investigations - Other, specify
3%
Bone pain
3%
Paresthesia
3%
Peripheral sensory neuropathy
3%
Dyspnea
100%
80%
60%
40%
20%
0%
Study treatment Arm
90Y-DOTA-tyr3-Octreotide

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Older AdultsExperimental Treatment1 Intervention
Older adults will be given a 10 g oral bolus of amino acids.
Group II: YoungActive Control1 Intervention
Young adults will be given a 10 g oral bolus of amino acids.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Amino Acids
2019
Completed Phase 2
~130

Find a Location

Who is running the clinical trial?

Purdue UniversityLead Sponsor
222 Previous Clinical Trials
72,632 Total Patients Enrolled
2 Trials studying Aging
65 Patients Enrolled for Aging
Chad C Carroll, PhDPrincipal InvestigatorPurdue University
1 Previous Clinical Trials
7 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can individuals aged 40 and older be included in the experiment?

"Per the study's inclusion criteria, participants must be between their 21st and 75th birthdays. Meanwhile, there is one trial for minors while an additional 239 studies are available to those over 65 years of age."

Answered by AI

Is this medical trial still accepting new participants?

"Accurate. Accessing data from clinicaltrials.gov reveals that this medical study, initially posted in September 2019, is no longer accepting participants at the present moment. Fortunately, there are 246 other trials actively seeking patient participation right now."

Answered by AI

Who qualifies as an eligible participant for this experiment?

"For this clinical trial, 30 people aged between 21 and 75 are needed. Crucially, candidates must satisfy the following conditions: -."

Answered by AI
~4 spots leftby Mar 2025